38 アンギュサイクリン系抗生物質TAN-1085の全合成(口頭発表の部)
スポンサーリンク
概要
- 論文の詳細を見る
TAN-1085 (1) is an antibiotic of Streptomyces origin, which has attracted considerable synthetic interest due to the unique structure, a curved tetracyclic core glycosylated with a rhodinose, and important biological activities. These structual features as well as the significant biological activities led us to undertake the synthesis of this class of compounds. We report herein the first total synthesis of 1. Although initial study for the key thermal reaction with 2 occurred only the [1,7]-shift of allylic hydrogen, thereby giving enol ether 4. However, we discovered that compound 18 could be directly converted to naphthodialdehyde 19 under the Swern oxidation conditions, where the ring opening of benzocyclobutane and subsequent 6π-closure occurred at room temperature. Stereoselective pinacol cyclization by using Sml_2, followed by direct quenching of the resulting pinacolization product with benzoyl chloride exclusively gave C(5)-benzoate 21 in good yield. Glycosylation of 22 was conducted by the reaction with glycosyl donor 23 in the presence of BF_3・OEt_2, giving an 1:1 mixture of 24 and 25. Although stereochemistries of aglycon part of these were not determined, each of these was converted to the final product. One of these was identified as the natural form by comparison with authentic specimen 1. In conclusion, the first synthesis of TAN-1085 (1) was achieved. Currently we are studying the asymmetric synthesis of 1 without resort to diastereomer separation.
- 天然有機化合物討論会の論文
- 2003-09-01
著者
-
鈴木 啓介
東工大院理工
-
大森 建
東工大院理工
-
森 啓二
東工大院理工
-
石川 勇次
東工大院理工
-
鶴田 英之
東工大院理工
-
石川 勇次
東工大院理工:crest
-
鶴田 英之
東工大院理工:crest
関連論文
- 32(D-2) プラジミシン-ベナノミシン系抗生物質の全合成(口頭発表の部)
- 28 プラジミシン・ベナノミシン系化合物の合成研究(口頭発表の部)
- 937 界面き裂の塑性変形を伴う破壊挙動に関する有限要素解析
- アトロプ選択的反応に関する最近の話題
- 27 抗生物質TAN-1085の不斉全合成(口頭発表の部)
- 38 アンギュサイクリン系抗生物質TAN-1085の全合成(口頭発表の部)
- 第15回IUPAC有機合成化学国際会議(IUPAC ICOS-15)を終えて : 講演ハイライト
- 20 セラガキノンAの全合成(口頭発表の部)